Combination of EGFR-TKIs with chemotherapy versus chemotherapy or EGFR-TKIs alone in advanced NSCLC patients with EGFR mutation

PURPOSE: Both epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) and chemotherapy are widely applied for the treatment of advanced non-small-cell lung cancer (NSCLC) with EGFR mutations, and the combination of EGFR-TKIs and chemotherapy has been used for advanced NSCLC patients;...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Biologics
Main Authors: Wen, Miaomiao, Xia, Jinghua, Sun, Ying, Wang, Xuejiao, Fu, Xianghui, Zhang, Yanning, Zhang, Zhipei, Zhou, Yongan, Li, Xiaofei
Formato: Artigo
Idioma:Inglês
Publicado em: Dove Medical Press 2018
Assuntos:
Perspectives
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6280904/
https://ncbi.nlm.nih.gov/pubmed/30555222
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/BTT.S169305
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados